Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

The pathology of hereditary breast cancer.

Honrado E, Benítez J, Palacios J.

Hered Cancer Clin Pract. 2004 Jul 15;2(3):131-8. doi: 10.1186/1897-4287-2-3-131.

PMID:
20233467
[PubMed]
2.

Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.

Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M, Hegardt C, Edén P, Peterson C, Malmström P, Isola J, Borg A, Fernö M.

Clin Cancer Res. 2007 Apr 1;13(7):1987-94.

PMID:
17404078
[PubMed - indexed for MEDLINE]
Free Article
3.

Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?

Murphy LC, Watson PH.

Endocr Relat Cancer. 2006 Jun;13(2):327-34. Review.

PMID:
16728566
[PubMed - indexed for MEDLINE]
Free Article
4.

BRCA1 in hormonal carcinogenesis: basic and clinical research.

Rosen EM, Fan S, Isaacs C.

Endocr Relat Cancer. 2005 Sep;12(3):533-48. Review.

PMID:
16172191
[PubMed - indexed for MEDLINE]
Free Article
5.

Breast cancer predisposing alleles in Poland.

Górski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbański K, Mituś J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Tołoczko-Grabarek A, Medrek K, Masojć B, Mierzejewski M, Kowalska E, Narod SA, Lubiński J.

Breast Cancer Res Treat. 2005 Jul;92(1):19-24.

PMID:
15980987
[PubMed - indexed for MEDLINE]
6.

Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer.

Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA.

Clin Cancer Res. 2004 Nov 15;10(22):7490-9.

PMID:
15569979
[PubMed - indexed for MEDLINE]
Free Article
7.

Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers.

O'Neill PA, Davies MP, Shaaban AM, Innes H, Torevell A, Sibson DR, Foster CS.

Br J Cancer. 2004 Nov 1;91(9):1694-702.

PMID:
15477865
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.

Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson JA, Rochefort H.

Clin Cancer Res. 2004 Sep 1;10(17):5769-76.

PMID:
15355905
[PubMed - indexed for MEDLINE]
Free Article
9.

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

van der Groep P, Bouter A, van der Zanden R, Menko FH, Buerger H, Verheijen RH, van der Wall E, van Diest PJ.

J Natl Cancer Inst. 2004 May 5;96(9):712-3; author reply 714. No abstract available.

PMID:
15126610
[PubMed - indexed for MEDLINE]
Free Article
10.

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.

Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA.

Cancer Res. 2004 Feb 1;64(3):830-5.

PMID:
14871808
[PubMed - indexed for MEDLINE]
Free Article
11.

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.

Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K, Foulkes WD.

Breast Cancer Res. 2004;6(1):R8-R17. Epub 2003 Oct 24.

PMID:
14680495
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA.

J Natl Cancer Inst. 2003 Oct 1;95(19):1482-5.

PMID:
14519755
[PubMed - indexed for MEDLINE]
Free Article
13.

Repeated observation of breast tumor subtypes in independent gene expression data sets.

Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23. Epub 2003 Jun 26.

PMID:
12829800
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.

Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.

Cancer. 2003 Jan 1;97(1):1-11.

PMID:
12491499
[PubMed - indexed for MEDLINE]
Free Article
15.

Estrogen receptor-beta expression in hereditary breast cancer.

Daidone MG, Veneroni S, Cappelletti V, Radice P, Pierotti MA, Younes M.

J Clin Oncol. 2002 Sep 1;20(17):3752-3; author reply 3753. No abstract available.

PMID:
12202682
[PubMed - indexed for MEDLINE]
Free Article
16.

Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?

Speirs V.

J Pathol. 2002 Jun;197(2):143-7. Review.

PMID:
12015736
[PubMed - indexed for MEDLINE]
17.

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF.

J Clin Oncol. 2002 May 1;20(9):2310-8.

PMID:
11981002
[PubMed - indexed for MEDLINE]
Free Article
18.

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T.

Int J Cancer. 2002 Feb 1;97(4):466-71.

PMID:
11802208
[PubMed - indexed for MEDLINE]
19.

p300 Modulates the BRCA1 inhibition of estrogen receptor activity.

Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM.

Cancer Res. 2002 Jan 1;62(1):141-51.

PMID:
11782371
[PubMed - indexed for MEDLINE]
Free Article
20.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74.

PMID:
11553815
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk